ARCHIVES

FDA Approves Rituxan For CLL

This article is from The Cancer Letter archive.

Vol. 36 No. 06 | February 19, 2010

Download PDF Visit The Full Archive

Related Articles

NCAB Committee Approves Concepts For Recompetition Of CIDAC, Two Other Contracts

July 1, 1983

In Brief: Ruddon To Head Eppley Institute; Shapiro elected ACR President; ACR Medalists Named

November 3, 1989

Funding opportunities listed.

April 30, 2004

President, First Lady Visit Clinical Center, Hail ‘Compassion’

January 12, 1990

Trials Suspended At Oklahoma Over Study Of Cancer Vaccine.

July 14, 2000

NCI Advisory Group, Other Cancer Meetings For Feb., March Listed

January 25, 1991